Results 241 to 250 of about 119,611 (303)

Sex-Specific Differences in Management and Outcomes of Cardiogenic Shock Patients With and Without Ischemic Cardiomyopathy. [PDF]

Korean Circ J
Park IH, Kim CH, Jang WJ, Oh JH, Lee WS, Yang JH, Gwon HC.   +6 more
europepmc   +1 more source

Simultaneous free-breathing T1, T2, and T1ρ mapping for myocardial fibrosis detection in non-ischemic cardiomyopathy: A comparative study with conventional techniques. [PDF]

J Cardiovasc Magn Reson
Wu Y, Qian X, Liu K, Lyu Z, Wang S, Chen Y, Chen L, Liu Z, Tian L, Jin H, Qi H, Zeng M.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ischemic cardiomyopathy

Progress in Cardiovascular Diseases, 1984
The term "ischemic cardiomyopathy" was used initially to describe a clinical syndrome that was indistinguishable from primary congestive cardiomyopathy but due to severe, diffuse coronary artery disease. The term has been expanded to include the larger category of myocardial disease secondary to coronary artery disease.
G A, Pantely, J D, Bristow
openaire   +2 more sources

Dystrophin: From non-ischemic cardiomyopathy to ischemic cardiomyopathy

Medical Hypotheses, 2008
Dystrophin and its associated proteins form a scaffold underneath the cardiomyocyte membrane and connect the intracellular cytoskeleton to the extracellular matrix. Dystrophin localizes at the X chromosome, whose mutations might result in Duchenne muscular dystrophy, Becker muscular dystrophy and X-linked dilated cardiomyopathy.
Qiang Sun, Zheng, Wan Gang, Guo, Zi Fan, Lu, Xiao Qin, Shi, Fei Fei, Su, Hua, Li   +5 more
openaire   +2 more sources

Q waves in ischemic cardiomyopathy

The International Journal of Cardiovascular Imaging, 2021
Q waves may be observed in the absence of non-viable tissue. However, their scintigraphic translation in patients with ischemic cardiomyopathy (ICM) has not been properly assessed. This study sought to establish the determinants of Q waves in the absence of non-viable tissue and the diagnostic accuracy in this population.
Eduard Ródenas-Alesina, Pablo Jordán, Lorena Herrador, Carina Espinet-Coll, Maria Nazarena Pizzi, Guillermo Romero-Farina, Santiago Aguadé-Bruix, Ignacio Ferreira-González   +7 more
openaire   +2 more sources

Ischemic cardiomyopathy: Pathophysiologic mechanisms

Progress in Cardiovascular Diseases, 1990
SCHEMIC cardiomyopathy is an anatomic condition emanating from a sustained imbalance between oxygen supply and demand of the heart that, in turn, leads to myocyte loss with resultant myocardial scarring and ventricular failure. Cell loss can occur as a result of focal narrowing or occlusion of the main coronary arteries by atherosclerosis, spasm of the
P, Anversa, E H, Sonnenblick
openaire   +2 more sources

Lipomatous metaplasia in ischemic cardiomyopathy

Journal of Cardiovascular Medicine, 2009
Lipomatous metaplasia is characterized by substitution of muscle fibers with adipose tissue in the context of a myocardial scar. Cardiac magnetic resonance is an accurate cardiac imaging technique with high tissue spatial resolution that can easily characterize scar tissue, adipose tissue and lipomatous metaplasia.
DI BELLA, Gianluca, GAETA, Michele, Anfuso C, ZITO, Concetta, Patanè S, CARERJ, Scipione, ARRIGO, Francesco, COGLITORE, Sebastiano   +7 more
openaire   +2 more sources